Lannett Co Inc (LCI)
(Delayed Data from NYSE)
$8.54 USD
+0.70 (8.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.54 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.54 USD
+0.70 (8.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.54 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Lannett (LCI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Lannett (LCI) delivered earnings and revenue surprises of 26.47% and 19.98%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Lannett (LCI) Q2 Earnings Expected to Decline
by Zacks Equity Research
Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in Lannett (LCI) Stock?
by Zacks Equity Research
Investors need to pay close attention to Lannett (LCI) stock based on the movements in the options market lately.
Is Lannett (LCI) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Lannett (LCI) stock is a good choice for value-oriented investors right now from multiple angles.
Lannett (LCI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Lannett (LCI) delivered earnings and revenue surprises of 10.00% and 5.86%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Lannett (LCI) Q1 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Lannett (LCI) Could Be Positioned for a Slump
by Zacks Equity Research
Lannett (LCI) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Lannett (LCI) Matches Q4 Earnings Estimates
by Zacks Equity Research
Lannett (LCI) delivered earnings and revenue surprises of 0.00% and -0.40%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Options Traders Expect Huge Moves in Lannett (LCI) Stock
by Zacks Equity Research
Lannett (LCI) needs investors to pay close attention to the stock based on moves in the options market lately.
Lannett Set to Lose Distribution Agreement With Key Supplier
by Zacks Equity Research
Lannett Company's (LCI) distribution agreement with key supplier, Jerome Stevens Pharmaceuticals, not to be renewed on expiry. Shares plunge.
Options Traders Expect Huge Moves in Lannett (LCI) Stock
by Zacks Equity Research
Investors need to pay close attention to Lannett (LCI) stock based on the movements in the options market lately.
Zacks Value Investor Highlights: Lannett, Emerge Energy, Roadrunner, GameStop and Micron
by Zacks Equity Research
Zacks Value Investor Highlights: Lannett, Emerge Energy, Roadrunner, GameStop and Micron
Should You Buy Stocks with P/Es under 5?
by Tracey Ryniec
Stocks with super low P/Es may seems like values, but investors should be cautious.
Is Lannett Company (LCI) a Great Stock for Value Investors?
by Zacks Equity Research
Is Lannett Company (LCI) a great pick from the value investor's perspective right now? Read on to know more.
Lannett (LCI) Q4 Earnings In Line, Stock Up on Solid View
by Zacks Equity Research
Lannett (LCI) reported in-line Q4 earnings and sales. The FDA approved multiple pending ANDAs during the quarter. Also, the company provided strong outlook for 2018.
Generic Drug Stocks Take a Hit: Here's Why
by Arpita Dutt
As generic drug pricing concerns loom large, Teva (TEVA) and other players in the generic market saw their shares tumble last week.
Take a Look at 5 Stocks with Attractive Price-to-Book Ratio
by Zacks Equity Research
When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool for identifying low-priced stocks that have high-growth prospects.
Zacks.com featured highlights: Vishay Intertechnology, Big Lots, Applied Materials and Lannett Company
by Zacks Equity Research
Zacks.com featured highlights: Vishay Intertechnology, Big Lots, Applied Materials and Lannett Company
4 Low Price-to-Cash-Flow Stocks for Assured Returns
by Zacks Equity Research
There are different valuation metrics to determine a stock's inherent strength but a random selection of ratios cannot serve your purpose.
Generic Drugmakers Tumble as Perrigo Discloses DoJ Search
by Arpita Dutt
With Perrigo (PRGO) disclosing that DoJ search warrants were executed at its corporate offices, industry-wide pricing practices are back in focus.
Is Lannett (LCI) a Great Stock for Value Investors?
by Zacks Equity Research
Lannett (LCI) seems to be a Great Stock for Value Investors on the back of its solid key value statistics.
The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems
Will Lannett (LCI) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Lannett Company, Inc. (LCI)
Express Scripts (ESRX) Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Express Scripts Holding Company (ESRX), is scheduled to report fourth-quarter 2016 results on Feb 14 after market closes.
Will Q4 Earnings Hold a Surprise for DaVita (DVA) Stock?
by Zacks Equity Research
DaVita HealthCare Partners Inc. (DVA) is set to report fourth-quarter 2016 results after market close on Feb 9.